Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,192,296
+$130,185 QoQ
Shares Held
24,382
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#1,463
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTRUST BANK NA holds $44,865,794 across 13 Drug Manufacturers - General names. JNJ ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,489 | $13,780,251 | |
| 2 | ABBV |
AbbVie Inc.
|
26,654 | $6,707,212 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
24,382 | $6,192,296 | |
| 4 | MRK |
Merck & Co., Inc.
|
28,996 | $3,725,986 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
24,402 | $3,082,948 | |
| 6 | AMGN |
Amgen Inc
|
7,840 | $2,839,020 | |
| 7 | AZN |
Astrazeneca PLC
|
10,427 | $1,977,167 | |
| 8 | NVS |
Novartis AG
|
11,153 | $1,747,897 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,192,296 | 24,382 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,062,111 | 24,800 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,148,915 | 24,880 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,498,845 | 24,263 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,567,475 | 23,355 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,613,155 | 21,787 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,927,397 | 20,242 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,220,455 | 19,872 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,853,481 | 19,523 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,636,629 | 22,989 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,684,329 | 23,506 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,837,368 | 24,638 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,007,072 | 24,209 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,772,235 | 24,337 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $4,497,685 | 25,461 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,914,758 | 23,964 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,382,011 | 24,686 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $4,257,949 | 24,025 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,077,453 | 23,835 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $3,905,715 | 24,184 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $3,920,152 | 23,796 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,116,803 | 25,049 | Shares | Sole | 2021-06-02 | |
| 2020-12-31 | $4,227,855 | 26,864 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,105,366 | 27,575 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $4,332,247 | 30,806 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $3,868,859 | 29,504 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||